The development assumes significance for India's $60-billion pharmaceutical industry amid concerns over the quality of drugs manufactured in the country.
Drugmakers may need designated expert to certify batches before sale

The development assumes significance for India's $60-billion pharmaceutical industry amid concerns over the quality of drugs manufactured in the country.
Key Takeaways
- Drugmakers may need designated expert to certify batches before sale.
- The development assumes significance for India's $60-billion pharmaceutical industry amid concerns over the quality of drugs manufactured in the country.
- The development assumes significance for India's $60-billion pharmaceutical industry amid concerns over the quality of drugs manufactured in the country.
Read Complete Original Article
Published originally on Livemint - News






